83 related articles for article (PubMed ID: 31900501)
1. Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Deakin CT; Campanilho-Marques R; Simou S; Moraitis E; Wedderburn LR; Pullenayegum E; Pilkington CA;
Arthritis Rheumatol; 2018 May; 70(5):785-793. PubMed ID: 29342499
[TBL] [Abstract][Full Text] [Related]
2. Perforations of the esophagus and stomach: what should I do?
Dimou F; Velanovich V
J Gastrointest Surg; 2015 Feb; 19(2):400-6. PubMed ID: 25451730
[TBL] [Abstract][Full Text] [Related]
3. Degos disease - malignant atrophic papulosis or cutaneointestinal lethal syndrome: rarity of the disease.
Pirolla E; Fregni F; Miura IK; Misiara AC; Almeida F; Zanoni E
Clin Exp Gastroenterol; 2015; 8():141-7. PubMed ID: 25926751
[TBL] [Abstract][Full Text] [Related]
4. Malignant atrophic papulosis treated with eculizumab and hirudin: a fatal case report and literature review.
Yu L; Wang Y; Tang X; Zhao X; Song Z
Front Cardiovasc Med; 2024; 11():1347587. PubMed ID: 38606375
[TBL] [Abstract][Full Text] [Related]
5. Clinical Images: Degos-like lesions in association with NXP-2 dermatomyositis.
Alhassan E; Wu KK; Christianakis S; Kim G; Crew A
ACR Open Rheumatol; 2023 Sep; 5(9):435. PubMed ID: 37219413
[No Abstract] [Full Text] [Related]
6. Degos disease: A rare disease with a fatal outcome.
Alonso JV; McKeown S; Montoro E
Med Clin (Barc); 2024 Apr; ():. PubMed ID: 38692989
[No Abstract] [Full Text] [Related]
7. Degos disease mimicking primary vasculitis of the CNS.
Gmuca S; Boos MD; Treece A; Narula S; Billinghurst L; Bhatti T; Laje P; Perman MJ; Vossough A; Harding B; Burnham J; Banwell B
Neurol Neuroimmunol Neuroinflamm; 2016 Apr; 3(2):e206. PubMed ID: 26894208
[No Abstract] [Full Text] [Related]
8. Challenges in the diagnosis and management of central line-associated blood stream infection due to Exophiala dermatitidis in an adult cancer patient.
Itoh N; Murakami H; Ishibana Y; Matsubara Y; Yaguchi T; Kamei K
J Infect Chemother; 2021 Sep; 27(9):1360-1364. PubMed ID: 33888421
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
[TBL] [Abstract][Full Text] [Related]
10. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
Nishi K; Ogura M; Tamai N; Gima M; Ide K; Koinuma G; Kamei K; Ito S
Pediatr Rheumatol Online J; 2022 Aug; 20(1):60. PubMed ID: 35927666
[TBL] [Abstract][Full Text] [Related]
11. Malignant atrophic papulosis: Two case reports.
Li ZG; Zhou JM; Li L; Wang XD
World J Clin Cases; 2022 Dec; 10(35):12971-12979. PubMed ID: 36569027
[TBL] [Abstract][Full Text] [Related]
12. Degos disease with multiple intestinal perforations: A missed-opportunity case report and literature review.
Ai W; Liang Z; Li F; Yu H
Front Cardiovasc Med; 2022; 9():910288. PubMed ID: 36324742
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal Involvement in Dermatomyositis.
Matas-Garcia A; Milisenda JC; Espinosa G; Cuatrecasas M; Selva-O'Callaghan A; Grau JM; Prieto-González S
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626355
[TBL] [Abstract][Full Text] [Related]
14. Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series.
Toplak N; Pimpale Chavan P; Rosina S; Dallos T; Rotem Semo O; Aguiar CL; Khubchandani R; Ravelli A; Patwardhan A
Front Pediatr; 2021; 9():810785. PubMed ID: 35280444
[TBL] [Abstract][Full Text] [Related]
15. Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis.
Doudouliaki T; Papadopoulou C; Deakin CT
Curr Rheumatol Rep; 2021 Mar; 23(4):24. PubMed ID: 33686540
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Calcinosis in Juvenile Dermatomyositis.
Kul Cinar O; Papadopoulou C; Pilkington CA
Curr Rheumatol Rep; 2021 Feb; 23(2):13. PubMed ID: 33555459
[TBL] [Abstract][Full Text] [Related]
17. Juvenile dermatomyositis resembling late-stage Degos disease with gastrointestinal perforations successfully treated with combination of cyclophosphamide and rituximab: case-based review.
Day W; Gabriel C; Kelly RE; Magro CM; Williams JV; Werner A; Gifford L; Lapsia SP; Aguiar CL
Rheumatol Int; 2020 Nov; 40(11):1883-1890. PubMed ID: 31900501
[TBL] [Abstract][Full Text] [Related]
18. Degos disease with dermatomyositis-like phenomenon: a diagnostic dilemma and a therapeutic challenge.
Gupta S; Dogra S; Saikia UN; Yadav S; Kanwar AJ
J Cutan Med Surg; 2011; 15(3):162-6. PubMed ID: 21561585
[TBL] [Abstract][Full Text] [Related]
19. [Köhlmeier-Degos disease (Malignant Atrophic Papulosis): a cause of recurrent multiple intestinal perforations].
Beuran M; Chiotoroiu AL; Morteanu S; Chilie A; Avram M; Roşu O; Vartic M; Creangă C; Mangrău A
Chirurgia (Bucur); 2009; 104(6):765-72. PubMed ID: 20187481
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
